Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial.
Background: Patients with acute ischaemic stroke and atrial fibrillation have an increased risk of early stroke recurrence, and anticoagulant treatment with heparins has been widely advocated, despite missing data on the balance of risk and benefit.Methods: Heparin in Acute Embolic Stroke Trial (HAE...
| Publicado en: | Lancet Vol. 355; no. 9211; pp. 1205 - 1211 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | clinical trial research tables/charts Journal Article |
| Publicado: |
Lancet
4/8/2000
|
| Acceso en línea: | Ver este registro en EBSCOhost |